Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Return on Assets (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Return on Assets for 8 consecutive years, with 0.71% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 62.0% year-over-year to 0.71%, compared with a TTM value of 0.71% through Sep 2025, down 62.0%, and an annual FY2024 reading of 0.26%, up 41.0% over the prior year.
  • Return on Assets was 0.71% for Q3 2025 at X4 Pharmaceuticals, up from 0.87% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.11% in Q2 2024 and bottomed at 1.04% in Q2 2022.
  • Average Return on Assets over 5 years is 0.6%, with a median of 0.69% recorded in 2023.
  • Peak annual rise in Return on Assets hit 110bps in 2025, while the deepest fall reached -98bps in 2025.
  • Year by year, Return on Assets stood at 0.75% in 2021, then rose by 6bps to 0.7% in 2022, then increased by 10bps to 0.63% in 2023, then skyrocketed by 63bps to 0.23% in 2024, then tumbled by -207bps to 0.71% in 2025.
  • Business Quant data shows Return on Assets for XFOR at 0.71% in Q3 2025, 0.87% in Q2 2025, and 0.11% in Q1 2025.